Cargando…

Interaction effects of significant risk factors on low bone mineral density in ankylosing spondylitis

BACKGROUND: To analyze individually and interactively critical risk factors, which are closely related to low bone mineral density (BMD) in patient with ankylosing spondylitis (AS). METHODS: A total of 249 AS patients who visited China-Japan Friendship Hospital were included in this training set. Pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wenting, Mu, Wenjun, Jefferies, Caroline, Learch, Thomas, Ishimori, Mariko, Wu, Juan, Yan, Zeran, Zhang, Nan, Tao, Qingwen, Kong, Weiping, Yan, Xiaoping, Weisman, Michael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2023
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676083/ https://www.ncbi.nlm.nih.gov/pubmed/38025753 http://dx.doi.org/10.7717/peerj.16448

Ejemplares similares

Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis
por: Hwang, Mark C., et al.
Publicado: (2021)

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
por: Visvanathan, S, et al.
Publicado: (2008)

Harmonization, data management, and statistical issues related to prospective multicenter studies in Ankylosing spondylitis (AS): Experience from the Prospective Study Of Ankylosing Spondylitis (PSOAS) cohort
por: Rahbar, Mohammad H., et al.
Publicado: (2018)

Relationship between the gut and the spine: a pilot study of first-degree relatives of patients with ankylosing spondylitis
por: Kehl, Amy S, et al.
Publicado: (2017)

Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis
por: Brionez, Tamar F, et al.
Publicado: (2009)

The bone mineral density of hip joint was reduced in the initial stage of ankylosing spondylitis?
por: Cai, Peng Li, et al.
Publicado: (2020)

Surgical Stabilization Improves Survival of Spinal Fractures Related to Ankylosing Spondylitis
por: Robinson, Yohan, et al.
Publicado: (2015)

Predicting the outcome of ankylosing spondylitis therapy
por: Vastesaeger, Nathan, et al.
Publicado: (2011)

The bone bridge significantly affects the decrease in bone mineral density measured with quantitative computed tomography in ankylosing spondylitis
por: Lee, So Yun, et al.
Publicado: (2021)

Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes
por: Klingberg, Eva, et al.
Publicado: (2013)

Factors relating to bone mineral density in young and middle-aged patients with ankylosing spondylitis
por: Wu, Xin, et al.
Publicado: (2021)

Bone and Cartilage Turnover Markers, Bone Mineral Density, and Radiographic Damage in Men with Ankylosing Spondylitis
por: Park, Min-Chan, et al.
Publicado: (2008)

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis
por: Arends, Suzanne, et al.
Publicado: (2020)

Does Gender Impact a Diagnosis of Ankylosing Spondylitis?
por: Hwang, Mark C., et al.
Publicado: (2022)

Changes in bone mineral density and bone metabolic indexes in ankylosing spondylitis mouse model complicated with osteoporosis
por: Hu, Zi-Bing, et al.
Publicado: (2018)

Immune mechanism of low bone mineral density caused by ankylosing spondylitis based on bioinformatics and machine learning
por: Zhang, Ding, et al.
Publicado: (2022)

Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab
por: Wagner, Carrie, et al.
Publicado: (2011)

Treat Ankylosing Spondylitis with Methazolamide
por: Chang, Xiaotian, et al.
Publicado: (2011)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis
por: Wang, Danmin, et al.
Publicado: (2017)

Bone mineral density, bone metabolism‐related factors, and microRNA‐218 are correlated with disease activities in Chinese ankylosing spondylitis patients
por: Liu, Jiayan, et al.
Publicado: (2022)

Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time
por: Doughem, Karim, et al.
Publicado: (2020)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
por: Sieper, Joachim, et al.
Publicado: (2014)

Advances in nanomedicine for the treatment of ankylosing spondylitis
por: Xi, Yanhai, et al.
Publicado: (2019)

Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study
por: Matzkies, Franziska G, et al.
Publicado: (2012)

High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review
por: van der Weijden, M. A. C., et al.
Publicado: (2012)

Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
por: Juhász, Balázs, et al.
Publicado: (2021)

Alterations in the gut virome in patients with ankylosing spondylitis
por: Li, Chen, et al.
Publicado: (2023)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
por: Braun, Jürgen, et al.
Publicado: (2011)

Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis
por: Sieper, Joachim, et al.
Publicado: (2011)

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
por: Braun, Jürgen, et al.
Publicado: (2011)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
por: Deodhar, Atul, et al.
Publicado: (2015)

Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study
por: Mundwiler, Matthew L, et al.
Publicado: (2009)

Update on the treatment of ankylosing spondylitis
por: Maksymowych, Walter P
Publicado: (2007)

Ankylosing spondylitis: yesterday and today.
por: Spencer, D G, et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_vdk9qo5j9gj3ndp1lejqabf4fq